ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Hezla
|
297 |
102K |
25 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
297
|
102K
|
25
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
17 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
1.6K
|
479K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
2 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
1.6K
|
479K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
10 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
1.6K
|
479K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Shareholder Update
|
|
Hezla
|
271 |
82K |
20 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
271
|
82K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
12 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1.6K
|
479K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Results of AGM
|
|
Hezla
|
199 |
55K |
15 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
199
|
55K
|
15
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Results of AGM
|
|
Hezla
|
199 |
55K |
22 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
199
|
55K
|
22
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
4 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
1.6K
|
479K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
36 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
1.6K
|
479K
|
36
|
|
ASX - By Stock
|
AEV Lithium |
Re:
LFP battery/Phosphate news
|
|
Hezla
|
1.4K |
665K |
10 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
1.4K
|
665K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
13 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
1.6K
|
479K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
Hezla
|
1.6K |
479K |
23 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
1.6K
|
479K
|
23
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Investor Presentation
|
|
Hezla
|
50 |
13K |
10 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
50
|
13K
|
10
|
|
ASX - By Stock
|
AEV Lithium |
Re:
LFP battery/Phosphate news
|
|
Hezla
|
1.4K |
665K |
8 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
1.4K
|
665K
|
8
|
|
ASX - By Stock
|
NNG |
Re:
IPO - Nexion Group Ltd - 20 January 2021 #
|
|
Hezla
|
80 |
45K |
0 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
80
|
45K
|
0
|
|
ASX - By Stock
|
NNG |
Re:
IPO - Nexion Group Ltd - 20 January 2021 #
|
|
Hezla
|
80 |
45K |
0 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
80
|
45K
|
0
|
|
ASX - By Stock
|
NNG |
Re:
IPO - Nexion Group Ltd - 20 January 2021 #
|
|
Hezla
|
80 |
45K |
0 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
80
|
45K
|
0
|
|
ASX - By Stock
|
WC8 |
Re:
Tenegraph Maps - Showing WC8 & De Grey
|
|
Hezla
|
16 |
4.9K |
0 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
16
|
4.9K
|
0
|
|
ASX - By Stock
|
WC8 |
Re:
Tenement Hearings 27/11/12
|
|
Hezla
|
87 |
18K |
7 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
87
|
18K
|
7
|
|
ASX - By Stock
|
WC8 |
Re:
Tenement Hearings 27/11/12
|
|
Hezla
|
87 |
18K |
4 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
87
|
18K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 OEM Contracts (various)
|
|
Hezla
|
50 |
18K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
50
|
18K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 OEM Contracts (various)
|
|
Hezla
|
50 |
18K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
50
|
18K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Breakout time?
|
|
Hezla
|
35 |
21K |
23 |
15/01/20 |
15/01/20 |
ASX - By Stock
|
35
|
21K
|
23
|
|
ASX - By Stock
|
IHL |
Re:
Share your ideas and thoughts.
|
|
Hezla
|
690 |
3.0M |
20 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
690
|
3.0M
|
20
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Files Patent over IHL-42X for OSA
|
|
Hezla
|
110 |
51K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
110
|
51K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Files Patent over IHL-42X for OSA
|
|
Hezla
|
110 |
51K |
5 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
110
|
51K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Share your ideas and thoughts.
|
|
Hezla
|
690 |
3.0M |
4 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
690
|
3.0M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Share your ideas and thoughts.
|
|
Hezla
|
690 |
3.0M |
2 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
690
|
3.0M
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL appoints Big-Pharma expert to lead drug development
|
|
Hezla
|
93 |
36K |
15 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
93
|
36K
|
15
|
|
ASX - By Stock
|
IHL |
Re:
ihl general
|
|
Hezla
|
258 |
90K |
5 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
258
|
90K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
ihl general
|
|
Hezla
|
258 |
90K |
1 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
258
|
90K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
ihl general
|
|
Hezla
|
258 |
90K |
6 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
258
|
90K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Details on IHL clinical trials
|
|
Hezla
|
92 |
23K |
11 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
92
|
23K
|
11
|
|
ASX - By Stock
|
IHL |
Details on IHL clinical trials
|
|
Hezla
|
92 |
23K |
46 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
92
|
23K
|
46
|
|
ASX - By Stock
|
IHL |
Re:
Ann: First Key Appointments to Medical Advisory Board
|
|
Hezla
|
79 |
29K |
5 |
04/09/19 |
04/09/19 |
ASX - By Stock
|
79
|
29K
|
5
|
|
ASX - By Stock
|
CTV |
Re:
General Discussion Thread
|
|
Hezla
|
1.2K |
653K |
1 |
31/08/19 |
31/08/19 |
ASX - By Stock
|
1.2K
|
653K
|
1
|
|
ASX - By Stock
|
CTV |
Re:
General Discussion Thread
|
|
Hezla
|
1.2K |
653K |
13 |
31/08/19 |
31/08/19 |
ASX - By Stock
|
1.2K
|
653K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Oil Supply Agreement and Brand Launch
|
|
Hezla
|
87 |
48K |
8 |
09/08/19 |
09/08/19 |
ASX - By Stock
|
87
|
48K
|
8
|
|
ASX - By Stock
|
CTV |
Re:
Ann: EN1 Run-Rate set to Significantly Outperform -Trading Update
|
|
Hezla
|
106 |
49K |
7 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
106
|
49K
|
7
|
|
ASX - By Stock
|
CTV |
Re:
Twittersphere
|
|
Hezla
|
40 |
11K |
4 |
04/07/19 |
04/07/19 |
ASX - By Stock
|
40
|
11K
|
4
|
|
ASX - By Stock
|
CTV |
Re:
Twittersphere
|
|
Hezla
|
40 |
11K |
10 |
04/07/19 |
04/07/19 |
ASX - By Stock
|
40
|
11K
|
10
|
|
ASX - By Stock
|
CTV |
Re:
Ann: EN1 Achieves Cash Flow Positive Q2 2019 4C & Commentary
|
|
Hezla
|
158 |
44K |
6 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
158
|
44K
|
6
|
|
ASX - By Stock
|
CTV |
Re:
TA/Charting
|
|
Hezla
|
912 |
271K |
6 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
912
|
271K
|
6
|
|
ASX - By Stock
|
SUV |
Re:
Ann: UltraCharge Completes Sale of Electrolyte IP
|
|
Hezla
|
39 |
34K |
12 |
01/07/19 |
01/07/19 |
ASX - By Stock
|
39
|
34K
|
12
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Results of Meeting
|
|
Hezla
|
259 |
89K |
7 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
259
|
89K
|
7
|
|
ASX - By Stock
|
SUV |
Re:
Ann: September 2018 Quarterly Report & Appendix 4C
|
|
Hezla
|
49 |
19K |
4 |
04/11/18 |
04/11/18 |
ASX - By Stock
|
49
|
19K
|
4
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Hezla
|
86 |
38K |
6 |
04/11/18 |
04/11/18 |
ASX - By Stock
|
86
|
38K
|
6
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Hezla
|
86 |
38K |
44 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
86
|
38K
|
44
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Hezla
|
86 |
38K |
26 |
30/09/18 |
30/09/18 |
ASX - By Stock
|
86
|
38K
|
26
|
|